SL
Sellas Life Sciences Group Inc
🇺🇸XNAS.SLSUnited StatesHealthcare
$11.66USDup +0.49 (+4.39%)ClosedEnd of day1:50 AM
Price$11.66+0.49 (+4.39%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US81642T2096
- CUSIP
- 74978T109
Company
- Employees
- 13
- Headquarters
- New York, United States
- CEO
- Dr. Angelos M. Stergiou M.D., ScD h.c.
Market
- Shares outstanding
- 201.9M
- Market cap
- $2.35B
Highlights
- Market cap
- $2.26B
- EPS LTM
- -$0.16calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -72.54calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$32.46M-23.62%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$28.42M+9.36%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.